Business
Macquarie trims CSL’s price target and outlook – The Australian Financial Review
As new COVID-19 cases surge in the US unemployment benefits and travel restrictions on Mexican citizens are limiting plasma collection….
Macquarie analysts estimated that foot traffic for about 100 of CSLs US-based plasma collection centres has remained subdued following a step-down in June, leading the investment bank to reduce its fiscal 2022 immunoglobulin volume growth assumptions.
Macquarie…
Continue Reading
-
Noosa News19 hours agoTeenaged driver killed in head-on collision at Brassall in Queensland
-
General19 hours agoQueensland second in world to identify women living with metastatic breast cancer
-
General10 hours agoConcerns over US AUKUS review dismissed by deputy PM
-
Noosa News22 hours agoUnits vs. houses: A tale of two cities